Document is current
Any future updates will be listed below
-
Authors
Oudelaar, A. Marieke
Beagrie, Robert A. http://orcid.org/0000-0003-1076-5595
Gosden, Matthew http://orcid.org/0000-0002-0657-7666
de Ornellas, Sara http://orcid.org/0000-0002-7333-5456
Georgiades, Emily http://orcid.org/0000-0001-6356-0003
Kerry, Jon
Hidalgo, Daniel http://orcid.org/0000-0002-2615-2868
Carrelha, Joana
Shivalingam, Arun
El-Sagheer, Afaf H. http://orcid.org/0000-0001-8706-1292
Telenius, Jelena M.
Brown, Tom http://orcid.org/0000-0002-6538-3036
Buckle, Veronica J. http://orcid.org/0000-0003-1195-2608
Socolovsky, Merav http://orcid.org/0000-0001-6747-7960
Higgs, Douglas R. http://orcid.org/0000-0003-3579-8705
Hughes, Jim R. http://orcid.org/0000-0002-8955-7256
-
Funding
Funding for this research was provided by:
Medical Research Council
Wellcome
-
License Information
Text and Data Mining valid from 2020-06-01
Version of Record valid from 2020-06-01
-
More Information
Article History
Received: 6 February 2020
Accepted: 13 May 2020
First Online: 1 June 2020
Competing interests
: J.R.H. is founder and shareholder of Nucleome Therapeutics.
